Antirobe Aquadrops Actions

How times a day do you take this medicine?
sponsored

Actions of Antirobe Aquadrops in details

sponsored

Pharmacology: Pharmacodynamics: Although Antirobe Aquadrops phosphate is inactive in vitro, rapid in vivo hydrolysis converts this compound to the antibacterially active Antirobe Aquadrops. Antirobe Aquadrops has been shown to have in vitro activity against isolates of Propionibacterium acnes cultures tested [minimum inhibitory concentration (MICs) 0.4 mcg/mL]. This may account for its usefulness in acne. Free fatty acids on the skin surface have been decreased from approximately 14-2% following application of Antirobe Aquadrops.

Cross-resistance has been demonstrated between Antirobe Aquadrops and lincomycin. Antagonism has been demonstrated between Antirobe Aquadrops and erythromycin.

Topical Solution and Lotion:

In addition, Antirobe Aquadrops has shown a wide range of in vitro activities that are described in the inserts for oral and parenteral administration.

Antirobe Aquadrops has no fungicidal activity.

The in vitro inactive Antirobe Aquadrops phosphate is hydrolysed by phosphatases of the skin to active Antirobe Aquadrops base.

Pharmacokinetics: Following multiple topical applications of Antirobe Aquadrops phosphate at a concentration equivalent to Antirobe Aquadrops 10 mg/mL in an isopropyl alcohol and water solution, very low levels of Antirobe Aquadrops are present in the serum (0-3 ng/mL) and <0.2% of the dose is recovered in urine as Antirobe Aquadrops.

Following multiple topical applications of Antirobe Aquadrops phosphate at a concentration equivalent to Antirobe Aquadrops 10 mg/g in the gel formulation, 0.053% (morning) and 0.07% (evening) of the administered dose was recovered in the urine as Antirobe Aquadrops. Average absolute bioavailability was 1.6% and 2.2% after morning and evening doses, respectively.

Antirobe Aquadrops activity has been demonstrated in comedones from acne patients. The mean concentration of antibiotic activity in extracted comedones after application of Antirobe Aquadrops (10 mg/mL) in an isopropyl alcohol and water solution for 4 weeks was 597 mcg/g of comedonal material (range 0-1,490 mcg/g).

Geriatric Use: Clinical studies for topical Antirobe Aquadrops did not include sufficient numbers of subjects ≥65 years to determine whether they respond differently from younger subjects.

Toxicology: Preclinical Safety Data: Carcinogenesis: Long-term studies in animals have not been performed with Antirobe Aquadrops to evaluate carcinogenic potential.

Mutagenesis: Genotoxicity tests performed included a rat micronucleus test and an Ames Salmonella reversion test. Both tests were negative.

Impairment of Fertility: Fertility studies in rats treated orally with up to 300 mg/kg/day (approximately 1.1 times the highest recommended adult human dose based on mg/m2) revealed no effects on fertility or mating ability.

In oral embryofetal development studies in rats and SC embryofetal development studies in rats and rabbits, no developmental toxicity was observed except at doses that produced maternal toxicity.

How should I take Antirobe Aquadrops?

Before applying Antirobe Aquadrops, thoroughly wash the affected areas with warm water and soap, rinse well, and pat dry.

When applying the medicine, use enough to cover the affected area lightly. You should apply the medicine to the whole area usually affected by acne, not just to the pimples themselves. This will help keep new pimples from breaking out.

You should avoid washing the acne-affected areas too often. This may dry your skin and make your acne worse. Washing with a mild, bland soap 2 or 3 times a day should be enough, unless you have oily skin. If you have any questions about this, check with your doctor.

Topical Antirobe Aquadrops will not cure your acne. However, to help keep your acne under control, keep using Antirobe Aquadrops for the full time of treatment, even if your symptoms begin to clear up after a few days. You may have to continue using Antirobe Aquadrops every day for months or even longer in some cases. If you stop using Antirobe Aquadrops too soon, your symptoms may return. It is important that you do not miss any doses.

For patients using the topical foam form of Antirobe Aquadrops:

For patients using the topical solution form of Antirobe Aquadrops:

For patients using the topical suspension form of Antirobe Aquadrops:

Dosing

The dose of Antirobe Aquadrops will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of Antirobe Aquadrops. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

Missed Dose

If you miss a dose of Antirobe Aquadrops, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Antirobe Aquadrops administration

sponsored

Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.

Take this medicine with a full glass of water to keep it from irritating your throat.

Measure liquid medicine with a special dose-measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.

Take this medicine for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Skipping doses may also increase your risk of further infection that is resistant to antibiotics. Antirobe Aquadrops will not treat a viral infection such as the common cold or flu.

To be sure this medication is not causing harmful effects, your blood may need to be tested often. Your kidney or liver function may also need to be tested. Visit your doctor regularly.

If you need surgery, tell the surgeon ahead of time that you are using Antirobe Aquadrops. You may need to stop using the medicine for a short time.

Store at room temperature away from moisture and heat. Do not store Antirobe Aquadrops liquid in the refrigerator.

Antirobe Aquadrops pharmacology

sponsored

Mechanism of Action

Mechanism of action in acne vulgaris is unknown.

Pharmacodynamics

Pharmacodynamics of Antirobe Aquadrops Foam is unknown.

Pharmacokinetics

In an open label, parallel group study in 24 subjects with acne vulgaris, 12 subjects (3 male and 9 female) applied 4 grams of Antirobe Aquadrops Foam once-daily for five days, and 12 subjects (7 male and 5 female) applied 4 grams of a Antirobe Aquadrops gel, 1%, once daily for five days. On Day 5, the mean Cmax and AUC(0-12) were 23% and 9% lower, respectively, for Antirobe Aquadrops Foam than for the Antirobe Aquadrops gel, 1%.

Following multiple applications of Antirobe Aquadrops Foam, less than 0.024% of the total dose was excreted unchanged in the urine over 12 hours on Day 5.

Microbiology

No microbiology studies were conducted in the clinical trials with this product.

Antirobe Aquadrops binds to the 50S ribosomal subunits of susceptible bacteria and prevents elongation of peptide chains by interfering with peptidyl transfer, thereby suppressing protein synthesis. Antirobe Aquadrops has been shown to have in vitro activity against Propionibacterium acnes (P. acnes), an organism that has been associated with acne vulgaris; however, the clinical significance of this activity against P. acnes was not examined in clinical studies with Antirobe Aquadrops Foam. P. acnes resistance to Antirobe Aquadrops has been documented.

Inducible Antirobe Aquadrops Resistance

The treatment of acne with antimicrobials is associated with the development of antimicrobial resistance in P. acnes as well as other bacteria (e.g. Staphylococcus aureus, Streptococcus pyogenes). The use of Antirobe Aquadrops may result in developing inducible resistance in these organisms. This resistance is not detected by routine susceptibility testing.

Cross Resistance

Resistance to Antirobe Aquadrops is often associated with resistance to erythromycin.



References

  1. NCIt. "Clindamycin: NCI Thesaurus (NCIt) provides reference terminology for many systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.". https://ncit.nci.nih.gov/ncitbrowser... (accessed September 17, 2018).
  2. EPA DSStox. "Clindamycin: DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.". https://comptox.epa.gov/dashboard/ds... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Antirobe Aquadrops are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Antirobe Aquadrops. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported administration

No survey data has been collected yet


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 22 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2024 ndrugs.com All Rights Reserved